Neutrophils: Innate Effectors of TB Resistance?

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2018 Nov 30

PMID 30487797

Citations 38

Authors

Elouise E Kroon

Anna K Coussens

Craig Kinnear

Marianna Orlova

Marlo Moller

Allison Seeger

Robert J Wilkinson

Eileen G Hoal

Erwin Schurr

Affiliations

Soon will be listed here.

Abstract

Certain individuals are able to resist infection despite persistent and intense exposure. These persons do not exhibit adaptive immune priming as measured by tuberculin skin test (TST) and interferon-γ (IFN-γ) release assay (IGRA) responses, nor do they develop active tuberculosis (TB). Genetic investigation of individuals who are able to resist infection shows there are likely a combination of genetic variants that contribute to the phenotype. The contribution of the innate immune system and the exact cells involved in this phenotype remain incompletely elucidated. Neutrophils are prominent candidates for possible involvement as primers for microbial clearance. Significant variability is observed in neutrophil gene expression and DNA methylation. Furthermore, inter-individual variability is seen between the mycobactericidal capacities of donor neutrophils. Clearance of infection is favored by the mycobactericidal activity of neutrophils, apoptosis, effective clearance of cells by macrophages, and resolution of inflammation. In this review we will discuss the different mechanisms neutrophils utilize to clear infection. We discuss the duality between neutrophils' ability to clear infection and how increasing numbers of neutrophils contribute to active TB severity and mortality. Further investigation into the potential role of neutrophils in innate immune-mediated infection resistance is warranted since it may reveal clinically important activities for prevention as well as vaccine and treatment development.

Citing Articles

The TB27 Transcriptomic Model for Predicting Culture Conversion.

Reimann M, Avsar K, DiNardo A, Goldmann T, Gunther G, Hoelscher M Pathog Immun. 2025; 10(1):120-139.

PMID: 39911144 PMC: 11792529. DOI: 10.20411/pai.v10i1.770.

Advancing Roles and Therapeutic Potentials of Pyroptosis in Host Immune Defenses against Tuberculosis.

Yang J, Ma Y, Yu J, Liu Y, Xia J, Kong X Biomolecules. 2024; 14(10).

PMID: 39456188 PMC: 11505957. DOI: 10.3390/biom14101255.

Construction of circRNA-miRNA-mRNA ceRNA regulatory network and screening of diagnostic targets for tuberculosis.

Pu X, Sheng S, Fu Y, Yang Y, Xu G Ann Med. 2024; 56(1):2416604.

PMID: 39435612 PMC: 11497567. DOI: 10.1080/07853890.2024.2416604.

Fatty acid metabolism in neutrophils promotes lung damage and bacterial replication during tuberculosis.

Sankar P, Ramos R, Corro J, Mishra L, Nafiz T, Bhargavi G PLoS Pathog. 2024; 20(10):e1012188.

PMID: 39365825 PMC: 11482725. DOI: 10.1371/journal.ppat.1012188.

Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis.

Irvine E, Nikolov A, Khan M, Peters J, Lu R, Sixsmith J Nat Microbiol. 2024; 9(9):2369-2382.

PMID: 39174703 PMC: 11371646. DOI: 10.1038/s41564-024-01777-9.

References

Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K . Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia. 1997; 11(4):466-78. DOI: 10.1038/sj.leu.2400607. View

Lau Y, Chan G, Ha S, Hui Y, Yuen K . The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis. 1998; 26(1):226-7. DOI: 10.1086/517036. View

Law K, Weiden M, Harkin T, Chi C, Rom W . Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med. 1996; 153(2):799-804. DOI: 10.1164/ajrccm.153.2.8564135. View

Parente L, Solito E . Annexin 1: more than an anti-phospholipase protein. Inflamm Res. 2004; 53(4):125-32. DOI: 10.1007/s00011-003-1235-z. View

Berry M, Graham C, McNab F, Xu Z, Bloch S, Oni T . An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010; 466(7309):973-7. PMC: 3492754. DOI: 10.1038/nature09247. View

Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Babaei Jandaghi A, Farhoudi A . Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 2004; 134(3):253-9. DOI: 10.1159/000078774. View

Bober L, Grace M, Waters T, Sullivan L, Narula S . The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology. 1995; 29(2):111-9. DOI: 10.1016/0162-3109(94)00050-p. View

Futosi K, Fodor S, Mocsai A . Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol. 2013; 17(3):638-50. PMC: 3827506. DOI: 10.1016/j.intimp.2013.06.034. View

Neufert C, Pai R, Noss E, Berger M, Boom W, Harding C . Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J Immunol. 2001; 167(3):1542-9. DOI: 10.4049/jimmunol.167.3.1542. View

10.

Schwanke R, Marcon R, Bento A, Calixto J . EPA- and DHA-derived resolvins' actions in inflammatory bowel disease. Eur J Pharmacol. 2015; 785:156-164. DOI: 10.1016/j.ejphar.2015.08.050. View

11.

Dapino P, Dallegri F, Ottonello L, Sacchetti C . Induction of neutrophil respiratory burst by tumour necrosis factor-alpha; priming effect of solid-phase fibronectin and intervention of CD11b-CD18 integrins. Clin Exp Immunol. 1993; 94(3):533-8. PMC: 1534434. DOI: 10.1111/j.1365-2249.1993.tb08230.x. View

12.

Weisbart R, Golde D, Clark S, Wong G, Gasson J . Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature. 1985; 314(6009):361-3. DOI: 10.1038/314361a0. View

13.

Kimmey J, Huynh J, Weiss L, Park S, Kambal A, Debnath J . Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection. Nature. 2015; 528(7583):565-9. PMC: 4842313. DOI: 10.1038/nature16451. View

14.

Stein C, Zalwango S, Malone L, Thiel B, Mupere E, Nsereko M . Resistance and Susceptibility to Mycobacterium tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda. Am J Epidemiol. 2018; 187(7):1477-1489. PMC: 6031055. DOI: 10.1093/aje/kwx380. View

15.

Lyadova I . Neutrophils in Tuberculosis: Heterogeneity Shapes the Way?. Mediators Inflamm. 2017; 2017:8619307. PMC: 5463159. DOI: 10.1155/2017/8619307. View

16.

Bylund J, MacDonald K, Brown K, Mydel P, Collins L, Hancock R . Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur J Immunol. 2007; 37(4):1087-96. DOI: 10.1002/eji.200636651. View

17.

Morrison J, Pai M, Hopewell P . Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2008; 8(6):359-68. DOI: 10.1016/S1473-3099(08)70071-9. View

18.

Steinwede K, Maus R, Bohling J, Voedisch S, Braun A, Ochs M . Cathepsin G and neutrophil elastase contribute to lung-protective immunity against mycobacterial infections in mice. J Immunol. 2012; 188(9):4476-87. DOI: 10.4049/jimmunol.1103346. View

19.

Tan B, Meinken C, Bastian M, Bruns H, Legaspi A, Ochoa M . Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol. 2006; 177(3):1864-71. DOI: 10.4049/jimmunol.177.3.1864. View

20.

Nandi B, Behar S . Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med. 2011; 208(11):2251-62. PMC: 3201199. DOI: 10.1084/jem.20110919. View